Aurinia Pharmaceuticals Inc. (AUPH) Form SCHEDULE 13D/A — Jun 4, 2026
A reporting person has disclosed the purchase of approximately 814,606 shares of Aurinia Pharmaceuticals Inc. (AUPH) in the open market between May 29 and June 2, 2026. The transactions were executed at weighted average prices ranging from $15.28 to $15.35, with individual share prices falling between $14.97 and $15.50. This accumulation is reported on Schedule A of an amended Schedule 13D, which is typically filed by investors who intend to influence or control the management or policies of the issuer.
Key figures
- Total Debt
- 0
- Debt Amount
- 0
- Total Assets
- 0
- Cash Position
- 0
- Interest Rate
- 0
- Gross Proceeds
- 0
- Offering Price
- 0
- Shares Offered
- 0
- Shares Outstanding
- 0
- Price range max
- 15.5
- Price range min
- 14.97
- Transaction dates
- ["5/29/2026","6/1/2026","6/2/2026"]
- Weighted avg price
- 15.28
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.